Lombard Medical Limited
Mark Fletcher has extensive experience in quality management, regulatory compliance, and validation in the medical technology and pharmaceutical industries. Mark has a strong background in implementing and maintaining quality management systems, ensuring compliance with industry standards, and managing staff in both quality system and engineering functions. Mark has also been involved in software validation, manufacturing procedures implementation, and training record management throughout their career.
This person is not in any teams
Lombard Medical Limited
Lombard Medical Limited is an Oxfordshire, UK-based medical device company focused on the market for minimally invasive treatment of aortic aneurysms (TAA/AAA). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. Lombard also manufactures the Altura™ stent graft, an innovative ultra-low profile device with a unique easy to use design that lends itself to day case EVAR, and which has been widely used in the repair of other failing EVAR devices. Lombard now also supplies the Minos™ ultra-low profile AAA stent graft, as well as the low profile Hercules™ TAA system. We continue to innovate and look for ways to enhance and increase the options physicians have to treat their patients.